Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dental PCLBKK:D-R 87 3-Year EBITDA Growth Rate is 10.70% as of Jun. 2026. GuruFocus rates BKK:D-R with a GF Score™ of 87/100 and a GF Value™ of ฿3.00. The stock has 4 warning signs investors should review. Among 524 Healthcare Providers & Services companies, Dental PCL ranks better than 51.15% on this metric.
During the past 12 months, Dental PCL's average EBITDA Per Share Growth Rate was 39.70% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 10.70% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 36.30% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was -27.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Dental PCL was 64.50% per year. The lowest was -92.20% per year. And the median was -23.60% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Dental PCL 3-Year EBITDA Growth Rate Related Terms
BKK:D-R vs HCA, THC, EHC: 3-Year EBITDA Growth Rate Comparison
For the Medical Care Facilities subindustry, Dental PCL's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dental PCL 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dental PCL's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Dental PCL's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 10.70% mean?
Dental PCL (BKK:D-R) has a 3-Year EBITDA Growth Rate of 10.70% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Dental PCL and its competitors. According to the industry distribution chart, Dental PCL ranks #256 out of 524 companies in the Healthcare Providers & Services industry, placing it in the top 48.9%.
Is Dental PCL's 3-Year EBITDA Growth Rate too high?
Dental PCL's current 3-Year EBITDA Growth Rate is 10.70%. The Healthcare Providers & Services industry median 3-Year EBITDA Growth Rate is 9.90. Dental PCL's value of 10.70% is 8.1% above this industry median. Based on the distribution chart, Dental PCL ranks #256 out of 524 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Dental PCL has a GF Score™ of 87/100, reflecting its overall financial health beyond just this single metric.
How does Dental PCL's 3-Year EBITDA Growth Rate compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dental PCL ranks #256 out of 524 companies for 3-Year EBITDA Growth Rate. This puts Dental PCL in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 9.90. Dental PCL's value of 10.70% is 8.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 9.90, based on 524 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dental PCL's current 3-Year EBITDA Growth Rate of 10.70% is 8.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Dental PCL and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 9.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dental PCL's current 3-Year EBITDA Growth Rate is 10.70%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dental PCL stock overvalued right now?
Dental PCL (BKK:D-R) has a current 3-Year EBITDA Growth Rate of 10.70%. The stock's GF Value™ is ฿3.00, compared to a current price of ฿3.04 — trading 1.3% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 10.70% and 8.1% above the Healthcare Providers & Services industry median of 9.90. Dental PCL's overall GF Score™ is 87/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Dental PCL (BKK:D-R), the current 3-Year EBITDA Growth Rate is 10.70% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dental PCL (BKK:D-R) Overvalued in 2026?
Based on GuruFocus' analysis, Dental PCL stock appears to be overvalued.
The current stock price of ฿3.04 is trading 1.3% above its estimated GF Value™ of ฿3.00.
Key valuation signals for BKK:D-R:
3-Year EBITDA Growth Rate: 10.70%
GF Value™: ฿3.00 vs. price of ฿3.04 (1.3% above fair value)
Industry Position: 8.1% above the Healthcare Providers & Services median (#256 of 524)
No single metric tells the full story. See the BKK:D-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dental Corp PCL provides dental service, dental laboratory service, and distributes dental supplies and equipment. The group's operations involve two reportable business segments: Dental service and Distribution of dental supplies and equipment. The majority of its revenue is derived from the Dental service segment, which offers various dental treatments and services such as dental diagnosis, root canal treatments, cosmetic surgery, treatment of gum diseases, orthodontic dentistry services, etc. The group is managed and operates principally in Thailand.
87GF Score
Get the complete analysis for BKK:D-R
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:D-R has been successfully added to your 
